This announcement appears as a matter of record only
MTS Medication
Technologies
received $13,000,000 for
working capital from
LaSalle Bank and
Berwind Growth Capital
FOCUS Partner James C. Harper assisted in the negotiations as the representative of MTS Medication Technologies.